Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Remote monitoring momentum

This article was originally published in The Gray Sheet

Executive Summary

Congressional Budget Office, CMS and key congressional committee staff are in "a very detailed level of discussion" with AdvaMed about which codes should be included in legislation to reimburse physicians for remote monitoring of patients with heart failure and cardiac arrhythmia, according to AdvaMed CEO Steve Ubl. "We think working through these technical issues will provide important momentum for adding it to a Medicare bill this year," he said. The AdvaMed-backed bill, S. 631, has a roughly $100 million price tag over five years and would affect physicians monitoring patients with implantable device-connected networks such as Boston Scientific's Latitude, Medtronic's CareLink and St. Jude Medical's Housecall Plus (1"The Gray Sheet" Nov. 5, 2007, p. 5)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel